Yes all very positive. Would have been more interesting if there was commercial value attached to the announcement. There have been many positive announcements and noise and on trend no real focus on or disclosure of the commercial benefit, size, scale or when it might be substantial. Thats what we and the SP is waiting for. And still in their announcements the CEO is reluctatnt to split out US commercial revenue from clinical and engineering services. The question for the CEO here is why ?
Ann: Accelerating Commercialisation with Largest US A&A Practice, page-11
-
- There are more pages in this discussion • 16 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ADR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $9.102M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 435003 | 1.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.3¢ | 224800 | 1 |
View Market Depth
| Last trade - 16.12pm 27/09/2024 (20 minute delay) ? |
| ADR (ASX) Chart |
Day chart unavailable